| Line 1: |
Line 1: |
| − | {{unfinished}} | + | {{OpenPagesTop}} |
| − | | + | ==Introduction== |
| − | ==Description== | |
| | The clinical syndrome described by the term '''diabetes mellitus''' results from intolerance to glucose. It is a chronic disease caused by an absolute or relative deficiency of insulin and, although all body systems are ultimately affected, it is primarily a disorder of carbohydrate metabolism. The approximate incidence of the disease is 13 cases/10,000 dogs years at risk<ref name="one">Fall T, Hamlin HH, Hedhammar A, Kämpe O, Egenvall A. '''Diabetes mellitus in a population of 180,000 insured dogs: incidence, survival, and breed distribution.''' ''J Vet Intern Med. 2007 Nov-Dec;21(6):1209-16.''</ref>. | | The clinical syndrome described by the term '''diabetes mellitus''' results from intolerance to glucose. It is a chronic disease caused by an absolute or relative deficiency of insulin and, although all body systems are ultimately affected, it is primarily a disorder of carbohydrate metabolism. The approximate incidence of the disease is 13 cases/10,000 dogs years at risk<ref name="one">Fall T, Hamlin HH, Hedhammar A, Kämpe O, Egenvall A. '''Diabetes mellitus in a population of 180,000 insured dogs: incidence, survival, and breed distribution.''' ''J Vet Intern Med. 2007 Nov-Dec;21(6):1209-16.''</ref>. |
| | | | |
| | ===Aetiology=== | | ===Aetiology=== |
| − | Insulin is produced in the beta cells of the pancreatic islets of Langerhans and is released into the circulation to act on specific cell-surface receptors. Its release is stimulated by rising blood glucose concentration and it is principally insulin which is responsible for the post-prandial gluconeogenesis observed in humans and dogs. Several hormones (including corticosteroids, progesterone, oestrogen, growth hormone, glucagon and catecholamines) have an antagonistic effect to insulin and cause the blood glucose concentration to increase. Interruptions at any stage in this pathway may produce the clinical syndrome of diabetes mellitus, including: | + | [[Image:Diabetes Mellitus Type IV hypersensitivity.jpg|right|thumb|150px|Diabetes Mellitus-Brian Catchpole RVC 2008]] |
| − | *Failure to produce insulin resulting in an '''absolute deficiency''' - This may be due to [[Pancreas, Endocrine - Degenerative Pathology|degenerative changes in the beta cells]] or it may occur with severe exocrine pancreatic disease that disrupts the islets of Langerhans. The major example of the latter disease process is [[Pancreatitis - Dog and Cat|pancreatitis]] and, in cases of this diesase, diabetes mellitus is often found concurrently with [[Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency]]. Degeneration of the beta cells, whether it involves the immune system or not, results in '''type 1''' diabetes mellitus and miniature Poodles, Dachshunds and terriers appear to be predisposed to this condition. In humans, it is speculated that immune responses directed at certain pathogens (notably coxsackie virus B1) may cross-react with antigens expressed on the surface of beta cells resulting in immune-mediated destruction of these cells. Whether type 1 diabetes mellitus is associated with a similar misdirected immune response is not yet clear in small animals with several studies giving conflicting results as to the presence of autoantibodies directed at the beta cells at the point at which the disease is first diagnosed. | + | [[Insulin]] is produced in the beta cells of the pancreatic islets of Langerhans and is released into the circulation to act on specific cell-surface receptors. Its release is stimulated by rising blood glucose concentration and it is principally insulin which is responsible for the post-prandial cellular glucose uptake and storage observed in humans and dogs. Several hormones (including corticosteroids, progesterone, oestrogen, growth hormone, glucagon and catecholamines) have an antagonistic effect to insulin and cause the blood glucose concentration to increase. Interruptions at any stage in this pathway may produce the clinical syndrome of diabetes mellitus, including: |
| | + | *Failure to produce insulin resulting in an '''absolute deficiency''' - This may be due to [[Pancreas, Endocrine - Degenerative Pathology|degenerative changes in the beta cells]] or it may occur with severe exocrine pancreatic disease that disrupts the islets of Langerhans. The major example of the latter disease process is [[Pancreatitis|pancreatitis]] and, in cases of this diesase, diabetes mellitus is often found concurrently with [[Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency]]. Degeneration of the beta cells, whether it involves the immune system or not, results in '''type 1''' diabetes mellitus and miniature Poodles, Dachshunds and terriers appear to be predisposed to this condition. In humans, it is speculated that immune responses directed at certain pathogens (notably coxsackie virus B1) may cross-react with antigens expressed on the surface of beta cells resulting in immune-mediated destruction of these cells. Whether type 1 diabetes mellitus is associated with a similar misdirected immune response is not yet clear in small animals with several studies giving conflicting results as to the presence of autoantibodies directed at the beta cells at the point at which the disease is first diagnosed. The pathogenesis would be via [[Type IV Hypersensitivity|Type IV hypersensitivity]]. The CTLs react as if all the beta cells in the pancreas are infected by a virus, as it wrongly detects a self antigen presented by the MHC class I on the surface of the cell as foreign. Autoreactive CD8+ CTLs are inadvertently activated, destroying the beta cells, thus preventing the secretion of insulin and causing diabetes type 1 (see diagram). |
| | | | |
| | Cats may suffer from '''islet amyloidosis''' in which the protein amylin is deposited in the tissue and has directly cytotoxic effects on the beta cells. Amylin is a protein which is produced normally in the beta cells at the same rate as insulin and has synergistic effects on many aspects of metabolism. In situations where the synthesis of insulin is increased due to insulin resistance (see below), amylin is also produced in excess and it then forms aggregates that are deposited in the pancreatic tissue. | | Cats may suffer from '''islet amyloidosis''' in which the protein amylin is deposited in the tissue and has directly cytotoxic effects on the beta cells. Amylin is a protein which is produced normally in the beta cells at the same rate as insulin and has synergistic effects on many aspects of metabolism. In situations where the synthesis of insulin is increased due to insulin resistance (see below), amylin is also produced in excess and it then forms aggregates that are deposited in the pancreatic tissue. |
| Line 34: |
Line 34: |
| | Reductions in renal output allow ketone bodies and glucose to increase to ever higher concentrations in the blood. Water moves from the intracellular space to compensate for this high plasma osmolality and the alterations in cellular hydration may result in comas or seizures. | | Reductions in renal output allow ketone bodies and glucose to increase to ever higher concentrations in the blood. Water moves from the intracellular space to compensate for this high plasma osmolality and the alterations in cellular hydration may result in comas or seizures. |
| | | | |
| − | The combined effects of these metabolic derangements may be life-threatening and urgent medical intervention is required. | + | The combined effects of these metabolic derangements may be life-threatening and urgent medical intervention is required. |
| | + | |
| | + | '''[[Diabetic Ketoacidosis]]''' provides a complete review of the condition. |
| | | | |
| | ====Chronic Disease==== | | ====Chronic Disease==== |
| Line 40: |
Line 42: |
| | | | |
| | Diabetic animals may suffer from '''peripheral neuropathies''' and '''retinopathy''' and they will have some level of '''immunosuppression'''. Affected animals are therefore predisposed to the development of chronic skin and urinary tract infections. | | Diabetic animals may suffer from '''peripheral neuropathies''' and '''retinopathy''' and they will have some level of '''immunosuppression'''. Affected animals are therefore predisposed to the development of chronic skin and urinary tract infections. |
| | + | |
| | + | |
| | | | |
| | ==Signalment== | | ==Signalment== |
| | Diabetes mellitus is most common in mature dogs and it is twice as common in females than in males. Miniature Poodles, Dachshunds and terriers may suffer from degenerative changes and type 1 disease. Non-insulin dependent diabetes mellitus is paticularly common in obese indoor cats with low physical activity <ref>Slingerland LI, Fazilova VV, Plantinga EA, Kooistra HS, Beynen AC. '''Indoor confinement and physical inactivity rather than the proportion of dry food are risk factors in the development of feline type 2 diabetes mellitus.''' ''Vet J. 2009 Feb;179(2):247-53. Epub 2007 Oct 26.''</ref>. | | Diabetes mellitus is most common in mature dogs and it is twice as common in females than in males. Miniature Poodles, Dachshunds and terriers may suffer from degenerative changes and type 1 disease. Non-insulin dependent diabetes mellitus is paticularly common in obese indoor cats with low physical activity <ref>Slingerland LI, Fazilova VV, Plantinga EA, Kooistra HS, Beynen AC. '''Indoor confinement and physical inactivity rather than the proportion of dry food are risk factors in the development of feline type 2 diabetes mellitus.''' ''Vet J. 2009 Feb;179(2):247-53. Epub 2007 Oct 26.''</ref>. |
| | + | |
| | + | |
| | | | |
| | ==Diagnosis== | | ==Diagnosis== |
| Line 52: |
Line 58: |
| | *'''Muscle wasting''' occurs in advanced cases when body protein reserves are mobilised. | | *'''Muscle wasting''' occurs in advanced cases when body protein reserves are mobilised. |
| | *'''Hepatomegaly''' results from increased storage of glucose as glycogen in hepatocytes. Individual hepatocytes shown signs of hydropic change or 'cloudy swelling' as they accrue increasing amounts of glycogen. | | *'''Hepatomegaly''' results from increased storage of glucose as glycogen in hepatocytes. Individual hepatocytes shown signs of hydropic change or 'cloudy swelling' as they accrue increasing amounts of glycogen. |
| − | *'''Cataracts''' develop as the metabolism of the lens is altered to compensate for hypergycaemia. | + | *'''Cataracts''' develop as the metabolism of the lens is altered to compensate for hyperglycaemia. |
| | *'''Peripheral neuropathy''', manifesting as plantigrade stance. | | *'''Peripheral neuropathy''', manifesting as plantigrade stance. |
| | *'''Chronic or recurrent pyoderma''', '''urinary tract infection''' or '''respiratory tract infection''' due to relative immunosuppression. | | *'''Chronic or recurrent pyoderma''', '''urinary tract infection''' or '''respiratory tract infection''' due to relative immunosuppression. |
| Line 64: |
Line 70: |
| | *'''Vomiting''' and diarrhoea | | *'''Vomiting''' and diarrhoea |
| | *'''Ketotic breath''', whose odour resembles that of pear drops | | *'''Ketotic breath''', whose odour resembles that of pear drops |
| − | Many of these clinical signs are underlain by the reduced cardiac output that occurs with DKA due to the renal loss of water and electrolytes. Blood pressure and peripheral perfusion are therefore reduced, leading to eventual circulatory collapse, coma and death | + | Many of these clinical signs are underlain by the reduced cardiac output that occurs with DKA due to the renal loss of water and electrolytes. Blood pressure and peripheral perfusion are therefore reduced, leading to eventual circulatory collapse, coma and death. |
| | | | |
| | ===Diagnostic Imaging=== | | ===Diagnostic Imaging=== |
| Line 70: |
Line 76: |
| | | | |
| | ===Pathology=== | | ===Pathology=== |
| − | Pancretic biopsies are not generally used to diagnose diabetes mellitus. On gross and histological examination of tissues from affected animals, the following changes may be observed: | + | Pancretic biopsies are not generally used to diagnose diabetes mellitus. On gross and histological examination of tissues from affected animals, the following changes may be observed: |
| − | *The pancreas may appear normal or reduced in size due to fibrosis | + | *The pancreas may appear normal or reduced in size due to fibrosis. |
| | *In cats, deposition of amyloid (aggregated plaques of the protein amylin) is often observed. | | *In cats, deposition of amyloid (aggregated plaques of the protein amylin) is often observed. |
| | *Fatty change is consistently present in the liver and kidneys. | | *Fatty change is consistently present in the liver and kidneys. |
| Line 85: |
Line 91: |
| | | | |
| | ===Other Tests=== | | ===Other Tests=== |
| − | '''Fructosamine''' refers to the product of the non-enzymatic addition of glucose molecules to plasma proteins that are exposed to high blood glucose concentrations. Since these modifications occur slowly and becase plasma proteins have a relatively long half life, the level of fructosamine gives an indication of the average blood glucose concentration over the previous 2-3 weeks. Animals with diabetes mellitus are expected to have a fructosamine concentration >500 umol/l (normal <400(-500) umol/l). Low fructosamine levels are found with [[Insulinoma|insulinoma]]. | + | '''Fructosamine''' refers to the product of the non-enzymatic addition of glucose molecules to plasma proteins that are exposed to high blood glucose concentrations. Since these modifications occur slowly and because plasma proteins have a relatively long half life, the level of fructosamine gives an indication of the average blood glucose concentration over the previous 2-3 weeks. Animals with diabetes mellitus are expected to have a fructosamine concentration >500 umol/l (normal <400(-500) umol/l). Low fructosamine levels are found with [[Insulinoma|insulinoma]]. |
| | | | |
| | '''Glycosylated haemoglobin''' can be measured as a similar indicator to fructosamine as it is also formed by a non-enzymatic reaction between glucose and protein. Levels greater than 7% are supportive of a diagnosis of diabetes mellitus but the test is not widely available. | | '''Glycosylated haemoglobin''' can be measured as a similar indicator to fructosamine as it is also formed by a non-enzymatic reaction between glucose and protein. Levels greater than 7% are supportive of a diagnosis of diabetes mellitus but the test is not widely available. |
| Line 92: |
Line 98: |
| | | | |
| | An '''electrocardiogram''' should be performed in cases of DKA to assess the degree of cardiac compromise caused by hyperkalaemia. Common findings in this condition include bradycardia, reduced R wave amplitude, reduced or absent P waves, spiked T waves, a reduced Q-T interval and an increased P-R interval. | | An '''electrocardiogram''' should be performed in cases of DKA to assess the degree of cardiac compromise caused by hyperkalaemia. Common findings in this condition include bradycardia, reduced R wave amplitude, reduced or absent P waves, spiked T waves, a reduced Q-T interval and an increased P-R interval. |
| | + | |
| | + | |
| | | | |
| | ==Treatment== | | ==Treatment== |
| | Treatment is generally based on supplementing insulin and making alterations to the management of the animal that result in stabilisation of the disease. Animals with DKA require immediate stabilisation and intensive monitoring. | | Treatment is generally based on supplementing insulin and making alterations to the management of the animal that result in stabilisation of the disease. Animals with DKA require immediate stabilisation and intensive monitoring. |
| | + | |
| | ===Stabilisation=== | | ===Stabilisation=== |
| | Animals presenting with DKA are often collapsed, comatose and severely dehydrated. Stabilisation would involve the following aspects of care: | | Animals presenting with DKA are often collapsed, comatose and severely dehydrated. Stabilisation would involve the following aspects of care: |
| | *'''Intra-venous fluid therapy''' with a suitable product. The priorities of fluid therapy are to hydrate the animal and prevent further damage due to poor tissue perfusion and to provide sodium which will have been lost with the osmotic diuresis. With the latter aim in mind, 0.9% sodium chloride solution is recommended. Other clinicians prefer to use compound sodium lactate (Hartmann's solution) as it provides some buffering capacity and, because its potassium content is much lower than that of normal plasma, it is unlikely to worsen any hyperkalaemia. Fluid deficits should be replaced over 24 hours and fluids should not be infused at rates much above twice maintenance to prevent cerebral oedema for occurring due to rapid alterations in electrolyte concentrations. It would also be advisable to measure serum electrolyte concentrations regularly to prevent this effect from occurring. | | *'''Intra-venous fluid therapy''' with a suitable product. The priorities of fluid therapy are to hydrate the animal and prevent further damage due to poor tissue perfusion and to provide sodium which will have been lost with the osmotic diuresis. With the latter aim in mind, 0.9% sodium chloride solution is recommended. Other clinicians prefer to use compound sodium lactate (Hartmann's solution) as it provides some buffering capacity and, because its potassium content is much lower than that of normal plasma, it is unlikely to worsen any hyperkalaemia. Fluid deficits should be replaced over 24 hours and fluids should not be infused at rates much above twice maintenance to prevent cerebral oedema for occurring due to rapid alterations in electrolyte concentrations. It would also be advisable to measure serum electrolyte concentrations regularly to prevent this effect from occurring. |
| − | *'''Insulin''' should be provided to reverse the metabolic changes that have resulted in the crisis. Since the administration of insulin may also have marked consequences for electrolyte status, it is best to administer it gradually as an infusion of soluble insulin. The insulin solution (made up in 0.9% sodium chloride) should be administered through a separate fluid line to that used for conventional fluids and the solution should be run through this line to saturate the bindings sites along the plastic with insulin molecules. Blood glucose concentration should be measured every regularly. Alternatively, intermittent injections of insulin may be used at hourly intervals while also measuring the blood glucose concentration. | + | *'''Insulin''' should be provided to reverse the metabolic changes that have resulted in the crisis. Since the administration of insulin may also have marked consequences for electrolyte status, it is best to administer it gradually as an infusion of soluble insulin. The insulin solution (made up in 0.9% sodium chloride) should be administered through a separate fluid line to that used for conventional fluids and the solution should be run through this line to saturate the bindings sites along the plastic with insulin molecules. Blood glucose concentration should be measured regularly. Alternatively, intermittent injections of insulin may be used at hourly intervals while also measuring the blood glucose concentration. |
| | It is important that insulin is not administered too quickly because it causes both potassium and phosphate to move intracellularly with glucose. This can result in rebound hypoglycaemia, hypokalaemia, hypophosphataemia and hypomagnesaemia because the total body levels of these cations will probably have been reduced by the enforced osmotic diuresis). Severe hypophosphataemia may result in the development of haemolytic anaemia. Potassium may need to be supplemented from the outset and the rate at which insulin is administered should be reduced if the animal is hypokalaemic on presentation. Other electrolytes should only be supplemented after their serum levels have been measured. | | It is important that insulin is not administered too quickly because it causes both potassium and phosphate to move intracellularly with glucose. This can result in rebound hypoglycaemia, hypokalaemia, hypophosphataemia and hypomagnesaemia because the total body levels of these cations will probably have been reduced by the enforced osmotic diuresis). Severe hypophosphataemia may result in the development of haemolytic anaemia. Potassium may need to be supplemented from the outset and the rate at which insulin is administered should be reduced if the animal is hypokalaemic on presentation. Other electrolytes should only be supplemented after their serum levels have been measured. |
| | *'''Infections''' occur frequently, either as a cause or effect of DKA. Broad spectrum bactericidal antibiotics are generally recommended in all cases. | | *'''Infections''' occur frequently, either as a cause or effect of DKA. Broad spectrum bactericidal antibiotics are generally recommended in all cases. |
| Line 110: |
Line 119: |
| | | | |
| | ====Insulin==== | | ====Insulin==== |
| − | Recombinant insulin is available in a variety of different preparations. Soluble (or neutral) insulin is short-acting and administered by infusion but, when mixed with zinc and protamine, it has a much longer duration of action. '''Lente''' insulin (a zinc salt preparation) is used most commonly in dogs and it may given once or twice per day. '''Protamine zinc insulin''' (PZI) is usually used in cats as this species seems to be able to degrade insulin more quickly and it has a longer duration of action than the Lente preparations. Bovine insulin is usually used in Lente preparations but, in dogs that are thought to have developed antibodies to this, porcine insulin may be used as it is homologous to canine. An initial insulin dose should be selected and this should not be changed suddenly for three days to allow the animal to respond fully. Insulin has more predictable pharmacokinetics if given intra-muscularly. | + | Recombinant insulin is available in a variety of different preparations. Soluble (or neutral) insulin is short-acting and administered by infusion but, when mixed with zinc and protamine, it has a much longer duration of action. '''Lente''' insulin (a zinc salt preparation) is used most commonly in dogs and it may be given once or twice per day. '''Protamine zinc insulin''' (PZI) is usually used in cats as this species seems to be able to degrade insulin more quickly and it has a longer duration of action than the Lente preparations. Bovine insulin is usually used in Lente preparations but, in dogs that are thought to have developed antibodies to this, porcine insulin may be used as it is homologous to canine. An initial insulin dose should be selected and this should not be changed suddenly for three days to allow the animal to respond fully. Insulin has more predictable pharmacokinetics if given intra-muscularly. |
| | | | |
| − | In cats, PZI is usually given once per day, followed by a meal after approximately 30 minutes. A second dose of insulin is not usually required and, if it is required, a zinc-insulin preparation should be used instead of PZI as the latter may cumulative activity. | + | In cats, PZI is usually given once per day, followed by a meal after approximately 30 minutes. A second dose of insulin is not usually required and, if it is required, a zinc-insulin preparation should be used instead of PZI as the latter may have cumulative activity. |
| | | | |
| | In dogs, once daily dosing is often used but twice daily dosing (with injections at 12 hour intervals) is also an acceptable protocol. Meals are offered 30 minutes after each injection. | | In dogs, once daily dosing is often used but twice daily dosing (with injections at 12 hour intervals) is also an acceptable protocol. Meals are offered 30 minutes after each injection. |
| | + | |
| | ====Diet==== | | ====Diet==== |
| | =====Dogs===== | | =====Dogs===== |
| − | The diet fed to diabetic animals should be '''consistent''' and, at least initially, it should have a good caloric density to allow animals to regain weight. If the animal is obese at presentation, a programme of controlled weight loss should be instituted so that insulin resistance is also minimised. The diet should be '''low in simple carbohydrates''' which may induce the secretion of glucagon and other hormones antagonistic to insulin. A '''constant feeding schedule''' should be maintained, with the animal usually being fed twice per day at the same times. | + | The diet fed to diabetic animals should be '''consistent''' and, at least initially, it should have a good caloric density to allow animals to regain weight. If the animal is obese at presentation, a program of controlled weight loss should be instituted so that insulin resistance is also minimised. The diet should be '''low in simple carbohydrates''' which may induce the secretion of glucagon and other hormones antagonistic to insulin. A '''constant feeding schedule''' should be maintained, with the animal usually being fed twice per day at the same times. |
| | | | |
| | It has been shown that a higher dietary '''fibre''' content can help to achieve better stabilisation in cases of diabetes mellitus because this substrate forms a viscous gel in the intestine that slows the absorption of glucose<ref>Graham PA, Maskell E, Rawlings JM, Nash AS, Markwell PJ. '''Influence of a high fibre diet on glycaemic control and quality of life in dogs with diabetes mellitus.''' ''J Small Anim Pract. 2002 Feb;43(2):67-73.''</ref>. This effect is greatest with soluble fibre but soluble/insoluble fibre mixes are often suitable. | | It has been shown that a higher dietary '''fibre''' content can help to achieve better stabilisation in cases of diabetes mellitus because this substrate forms a viscous gel in the intestine that slows the absorption of glucose<ref>Graham PA, Maskell E, Rawlings JM, Nash AS, Markwell PJ. '''Influence of a high fibre diet on glycaemic control and quality of life in dogs with diabetes mellitus.''' ''J Small Anim Pract. 2002 Feb;43(2):67-73.''</ref>. This effect is greatest with soluble fibre but soluble/insoluble fibre mixes are often suitable. |
| | + | |
| | =====Cats===== | | =====Cats===== |
| | Similarly to dogs, the diet should be consistent and not contain a large proportion of simple carbohydrates. In cats with suspected non-insulin dependent diabetes mellitus, obesity should be corrected as a priority to reduce insulin resistance. Emaciated cats should be fed a diet with high caloric density. | | Similarly to dogs, the diet should be consistent and not contain a large proportion of simple carbohydrates. In cats with suspected non-insulin dependent diabetes mellitus, obesity should be corrected as a priority to reduce insulin resistance. Emaciated cats should be fed a diet with high caloric density. |
| Line 138: |
Line 149: |
| | | | |
| | ===Instability=== | | ===Instability=== |
| − | Animals that have previosuly been stabilised may suffer bouts of overt diabetes mellitus and even deteriotrate into DKA. | + | Animals that have previosly been stabilised may suffer bouts of overt diabetes mellitus and even deteriotrate into DKA. |
| | ====Causes of Instability==== | | ====Causes of Instability==== |
| | There are many documented reasons for this instability, of which the most common are problems with: | | There are many documented reasons for this instability, of which the most common are problems with: |
| | *'''Storage and use of insulin''' - Insulin should be stored in a fridge and should only be retained as long as is stated on its 'use by' date. The insulin should not be shaken vigorously before use and it should be kept out of sunlight. If it is to be given by infusion, the giving set should be generously run through as the insulin molecules will adsorb to the plastic of the set. | | *'''Storage and use of insulin''' - Insulin should be stored in a fridge and should only be retained as long as is stated on its 'use by' date. The insulin should not be shaken vigorously before use and it should be kept out of sunlight. If it is to be given by infusion, the giving set should be generously run through as the insulin molecules will adsorb to the plastic of the set. |
| − | *'''Administration of insulin''' - The insulin should be drawn up into a suitable insulin syringe and injected intramuscularly. Subcutaneous injection will result in variable pharmacokinetics. | + | *'''Administration of insulin''' - The insulin should be drawn up into a suitable insulin syringe and injected '''intramuscularly'''. Subcutaneous injection will result in variable pharmacokinetics. |
| − | *'''Response to insulin''' - Some animals will show signs of marked hypoglycaemia after administration of insulin but then begin to show signs of polyuria/polydipsia. If the dose is too great for the animal, antagonistic hormones will be released that will result in a rebound hyperglycaemia after a period of hypoglycaemia, a phenomenon called a '''Somogyi overswing'''. This is remedied by reducing the dose of insulin given to prevent the release of antagonistic hormones. | + | *'''Response to insulin''' - Some animals will show signs of marked hypoglycaemia after administration of insulin but then begin to show signs of polyuria/polydipsia. If the dose is too great for the animal, antagonistic hormones will be released that will result in a rebound hyperglycaemia after a period of hypoglycaemia, a phenomenon called a '''Somogyi overswing'''. This is remedied by reducing the dose of insulin given to prevent the release of antagonistic hormones. |
| − | *'''Rapid metabolism of insulin''' - Some animals metabolise insulin faster than others and begin to show signs of diabetes mellitus before their next dose is due. If insulin is given in the morning, glycosuria will often be detected in a morning urine sample. This is managed by increasing the insulin dosage or, preferably, giving two doses of insulin twelve hours apart. | + | *'''Rapid metabolism of insulin''' - Some animals metabolise insulin faster than others and begin to show signs of diabetes mellitus before their next dose is due. If insulin is given in the morning, glycosuria will often be detected in a morning urine sample. This is managed by increasing the insulin dosage or, preferably, giving two doses of insulin twelve hours apart. |
| | *'''Insulin resistance''' - Failure to respond to insulin may occur due to an immune response to the recombinant drug or because of some underlying disease that results in the production of factors antagonistic to insulin. If an immune response is suspected, porcine insulin should be used in preference to bovine as it is homologous to the canine molecule. Disease that cause insulin resistance are listed above but the most common causes of instability are infections (particularly cystitis or skin infections), dioestrus, pregnancy or stress. Infections should be treated and female animals should be neutered after they have been stabilised. | | *'''Insulin resistance''' - Failure to respond to insulin may occur due to an immune response to the recombinant drug or because of some underlying disease that results in the production of factors antagonistic to insulin. If an immune response is suspected, porcine insulin should be used in preference to bovine as it is homologous to the canine molecule. Disease that cause insulin resistance are listed above but the most common causes of instability are infections (particularly cystitis or skin infections), dioestrus, pregnancy or stress. Infections should be treated and female animals should be neutered after they have been stabilised. |
| | | | |
| Line 150: |
Line 161: |
| | A full history should be taken a complete clinical examination performed to try to determine whether any concurrent disease may be contributing to the clinical signs documented. Complete biochemical and haematological analysis of blood samples and examination of a urine sample may be indicated for the same reasons, especially to rule out the presence of a urinary tract infection. | | A full history should be taken a complete clinical examination performed to try to determine whether any concurrent disease may be contributing to the clinical signs documented. Complete biochemical and haematological analysis of blood samples and examination of a urine sample may be indicated for the same reasons, especially to rule out the presence of a urinary tract infection. |
| | | | |
| − | If the animal is not thought to suffer from stress-induced hyperglycaemia, it should be hospitalised and blood glucose concentrations should be measured every two hours after insulin has been administered and food offered in the normal pattern for the patient. Hourly blood samples may be necessary in some cases as the nadir of a Somogyi overswing may occur rapidly. The pattern of change of blood glucose concentration over time should help to define the cause of the instability. | + | If the animal is not thought to suffer from stress-induced hyperglycaemia, it should be hospitalised and blood glucose concentrations should be measured every two hours after insulin has been administered and food offered in the normal pattern for the patient. Hourly blood samples may be necessary in some cases as the nadir of a Somogyi overswing may occur rapidly. The pattern of change of blood glucose concentration over time should help to define the cause of the instability. |
| | | | |
| | ==Prognosis== | | ==Prognosis== |
| | The overall prognosis for animals with diabetes mellitus is dependent on multiple factors but the '''median survival time from diagnosis is two years in dogs''' with a relatively higher mortality in the six months following diagnosis<ref name="one">Fall T, Hamlin HH, Hedhammar A, Kämpe O, Egenvall A. '''Diabetes mellitus in a population of 180,000 insured dogs: incidence, survival, and breed distribution.''' ''J Vet Intern Med. 2007 Nov-Dec;21(6):1209-16.''</ref>. The quality of life of animals with diabetes mellitus should be monitored by both owners and veterinary surgeons. | | The overall prognosis for animals with diabetes mellitus is dependent on multiple factors but the '''median survival time from diagnosis is two years in dogs''' with a relatively higher mortality in the six months following diagnosis<ref name="one">Fall T, Hamlin HH, Hedhammar A, Kämpe O, Egenvall A. '''Diabetes mellitus in a population of 180,000 insured dogs: incidence, survival, and breed distribution.''' ''J Vet Intern Med. 2007 Nov-Dec;21(6):1209-16.''</ref>. The quality of life of animals with diabetes mellitus should be monitored by both owners and veterinary surgeons. |
| | + | |
| | + | {{Learning |
| | + | |flashcards = [[Small Animal Abdominal and Metabolic Disorders Q&A 06]]<br>[[Feline Medicine Q&A 15]] |
| | + | |powerpoints = [[E-Lecture:Canine Diabetes|Canine Diabetes e-lecture]] |
| | + | |literature search = [http://www.cabdirect.org/search.html?rowId=1&options1=AND&q1=%22Diabetes+Mellitus%22&occuring1=title&rowId=2&options2=AND&q2=&occuring2=freetext&rowId=3&options3=AND&q3=&occuring3=freetext&publishedstart=2000&publishedend=yyyy&calendarInput=yyyy-mm-dd&la=any&it=any&show=all&x=54&y=14 Diabetes mellitus publications since 2000] |
| | + | |
| | + | [http://www.cabdirect.org/search.html?rowId=1&options1=AND&q1=%22Diabetes+Mellitus%22&occuring1=title&rowId=2&options2=AND&q2=dogs&occuring2=od&rowId=3&options3=AND&q3=&occuring3=freetext&x=38&y=9&publishedstart=&publishedend=yyyy&calendarInput=yyyy-mm-dd&la=any&it=any&show=all Diabetes mellitus in dogs publications] |
| | + | |
| | + | [http://www.cabdirect.org/search.html?q=title%3A%28%22Diabetes+Mellitus%22%29+AND+od%3A%28cats%29 Diabetes mellitus in cats publications] |
| | + | |full text = [http://www.cabi.org/cabdirect/FullTextPDF/2009/20093017995.pdf ''' Diabetes in cats that require immunosuppressive therapy.''' Schermerhorn, T.; Gething, M.; Jones, B.; Australian Small Animal Veterinary Association, Bondi, Australia, 33rd World Small Animal Veterinary Association Congress, Dublin, Ireland, 20-24 August 2008, 2008, pp 457-458, 5 ref.] |
| | + | |
| | + | [http://www.cabi.org/cabdirect/FullTextPDF/2007/20073161530.pdf '''Diabetes mellitus in dogs - long term management.''' Kshama, M. A.; Deepti, B. R.; Sudha, G.; Intas Pharmaceuticals Ltd, Ahmedabad, India, Intas Polivet, 2007, 8, 1, pp 117-120, 5 ref.] |
| | + | |
| | + | [http://www.cabi.org/cabdirect/FullTextPDF/2006/20063240193.pdf '''Recent advances in diabetes mellitus.''' Schermerhorn, T.; The North American Veterinary Conference, Gainesville, USA, The North American Veterinary Conference 2003, Small Animal and Exotics. Orlando, Florida, USA, 18-22 January, 2003, 2003, pp 310-312] |
| | + | |
| | + | [http://www.cabi.org/cabdirect/FullTextPDF/2005/20053195425.pdf ''' Management of the complicated diabetic.''' Zoran, D. L.; Eastern States Veterinary Association, Gainesville, USA, Small animal and exotics. Proceedings of the North American Veterinary Conference, Volume 19, Orlando, Florida, USA, 8-12 January, 2005, 2005, pp 329-331, 4 ref.] |
| | + | |Vetstream = [https://www.vetstream.com/felis/Content/Disease/dis00139.asp Diabetes mellitus] |
| | + | }} |
| | | | |
| | ==References== | | ==References== |
| Line 160: |
Line 189: |
| | | | |
| | | | |
| − | [[Category:Liver_-_Degenerative_Pathology]][[Category:Cat]][[Category:Dog]] | + | |
| − | [[Category:To_Do_-_James]] | + | {{review}} |
| − | [[Category:To_Do_-_Review]] | + | |
| | + | {{OpenPages}} |
| | + | |
| | + | [[Category:Liver_-_Degenerative_Pathology]][[Category:Pancreatic Diseases - Cat]][[Category:Endocrine Diseases - Cat]][[Category:Neurological Diseases - Cat]][[Category:Immunological Diseases - Cat]][[Category:Liver Diseases - Cat]][[Category:Liver Diseases - Dog]][[Category:Pancreatic Diseases - Dog]][[Category:Endocrine Diseases - Dog]][[Category:Neurological Diseases - Dog]][[Category:Immunological Diseases - Dog]] |
| | + | [[Category:Cell Mediated Autoimmune Diseases]][[Category:Endocrine System - Pathology]] |
| | + | [[Category:Expert_Review]] |